You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +44 (0)20 7769 6707 or email: apus@templetonapus.com |
|
Most viewed
- 1. Dracen Pharmaceuticals Announces the Initiation of First-in-human Study of DRP-104 in Adult Patients With Advanced Solid Tumors
- 2. Coronavirus pandemic could impact cancer rates and care in the future
- 3. Daiichi Sankyo's Enhertu to treat HER2 positive metastatic gastric cancer gets Japanese approval
- 4. Worldwide Enteral Feeding Devices Industry to 2025 - Featuring Abbott Laboratories, Amsino International & Boston Scientific Among Others - ResearchAndMarkets.com
- 5. Top-Line Results Released from Huntington's Disease Study
- 6. Innova Therapeutics receives US FDA Rare Pediatric Disease Designation for IVT-8086 to treat osteosarcoma
- 7. How Toronto hospitals are bracing for COVID-19's second wave — and what they learned the first time around
- 8. 5 common coronavirus misconceptions and the science you need to know
- 9. Creativity & a Little Help From Her Baby Girl Helped This Mom Stay ‘Rock Solid' During Second Cancer, Leukemia
- 10. Cancer research projects slowed by Covid restrictions
Last updated at 2:37 GMT
Hot News Makers
Health/Pharma Companies
-
180321.50
-
11765.78
-
8191.61
-
8005.58
-
3809.48
-
692.96
-
501.15
-
453.09
-
427.48
-
418.52
Last updated at 2:10 GMT
© Copyright 2020 Templeton Apus. All rights reserved.
Made with 
and
in the EU & the UK
and
in the EU & the UK